Using a systematic approach and achieving run-to-run consistency are essential.

Optimizing Fermentation Processes for Biologics Manufacturing

Process and bioreactor performance are directly impacted by real-time monitoring capabilities.

Advances in Inline Monitoring for Improved Bioreactor Performance

Scale-up strategies for cell culture will require a deep understanding of overall bioprocess workflows.

A Look into Biologic Scale-Up Strategies

Feliza Mirasol is the science editor for 

Articles

Re-evaluating the basics of mAb production may be beneficial for the biopharma industry as a whole.

Remembering Raw Material Basics for mAb Production

The construction of Gritgen’s GMP facility strictly adheres to the global current GMP (CGMP) standards and complies with the regulatory guidelines of authoritative agencies including the National Medical Products Administration (NMPA), FDA, and the European Medicines Agency (EMA).

Gritgen Therapeutics Launches Commercial GMP Facility in China

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Using a systematic approach and achieving run-to-run consistency are essential. 

Grant Playter is the Assistant Editor for 

Sartorius’ Biostat STR now incorporates Repligen’s XCell ATF hardware.

Sartorius and Repligen Launch Upstream Processing Intensification System

MilliporeSigma has invested $25 million to expand its cell culture media production facility in Lenexa, Kan.

MilliporeSigma Expands Production Facility for Cell Culture Media

The choice of expression system requires wise consideration of product complexities.

Choosing the Right Expression System for Complex Modalities

The bioreactor scaler tool helps scaling between development and manufacturing and to de-risk scaling activities and ensure product quality.

Culture Biosciences and Cytiva to Collaborate on Innovative Upstream Bioprocessing 

Media developers and vector manufacturers face a combination of challenges and opportunities.